ZyVersa Therapeutics (ZVSA) Share-based Compensation (2022 - 2026)
ZyVersa Therapeutics (ZVSA) posted Share-based Compensation of $55,872 for Q1 2026, down 63.7% from $153,891 a year earlier.
Powered by 
Analysis
ZyVersa Therapeutics (ZVSA) Share-based Compensation (2022 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Share-based Compensation at ZyVersa Therapeutics was $141,981, down 77.7% year-over-year; for FY2025, it was $240,000, down 66.0% from FY2024.
- Annual Share-based Compensation has declined for three consecutive years, with a four-year compound annual growth rate of -50.9% (FY2021 to FY2025).
- In prior years, ZyVersa Therapeutics' Share-based Compensation was $705,567 in FY2024 (-40.9%), $1.19 million in FY2023 (-66.2%), $3.52 million in FY2022 and $4.14 million in FY2021.
- Quarterly Share-based Compensation has run from a low of $29,600 in Q3 2025 to a high of $1.94 million in Q1 2022 over five years.
- Across the past five years, year-over-year decline in Share-based Compensation ran from 31.2% in Q1 2025 to 81.6% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.78 Bn | 1,135.37 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 635.34 Bn | 553.86 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.48 Bn | 476.60 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 377.08 Bn | 331.46 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 304.13 Bn | 268.12 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.48 Bn | 241.16 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.75 Bn | 197.15 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.09 Bn | 168.29 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 249.00 Mn |
| 10 | ZyVersa Therapeutics | 404,796.06 | -599,719.94 | - | 55,872.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 55,872.00 |
| Sep 30, 2025 | 73,988.00 |
| Jun 30, 2025 | 59,199.00 |
| Mar 31, 2025 | 153,891.00 |
| Dec 31, 2024 | 160,665.00 |
| Sep 30, 2024 | 160,665.00 |
| Jun 30, 2024 | 160,664.00 |
| Mar 31, 2024 | 223,573.00 |
| Dec 31, 2023 | 296,714.00 |
| Sep 30, 2023 | 243,045.00 |
| Jun 30, 2023 | 365,742.00 |
| Mar 31, 2023 | 395,200.00 |
| Jun 30, 2022 | 695,940.00 |
| Mar 31, 2022 | 1.94 Mn |
API Access
ZyVersa Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ZVSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ZVSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ZVSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();